Affordable Insulin Now Act · House · Mar 31, 2022 · 232–193
Took Pharma and health care money, voted Pharma and health care's way: 46%. Took none: 39%.
46%
of 389 funded members voted its way
vs
39%
of 36 unfunded members did
$207K
average from the industry, members who voted its way
$219K
average from the industry, members who defied it
319
clients paid lobbyists to work this bill, $217M in the quarters they named it
Paid, and voted with the industry
- Brett Guthrie$2.3M
- Jason Smith$1.3M
- John Joyce$1.2M
- Gus Bilirakis$1.1M
- Darin LaHood$992K
Paid, and defied it
- Frank Pallone$1.6M
- Richard Neal$1.6M
- Richard Hudson$1.2M
- Raul Ruiz$1.2M
- Terri Sewell$1.2M
Capped out-of-pocket insulin costs at $35 a month in private plans as well as Medicare. Passed the House 232–193; the Senate only kept the Medicare cap. Pharma and health care wanted nay. "Funded" means $10K+ from the industry across every run since 2020.
The full detail →